Methods Validation and Flaws

Also susceptible Haemophilus spp., Neisseria spp. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. Group B (Str. Indications of drug: lower respiratory retransmit (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. pneumoniae, Str. epidermidis (strains sensitive to methicillin), Micrococcus spp., Str. pyogenes (and other beta-hemolytic streptococci), Str. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main pharmaco-therapeutic action: bactericidal action, mechanism of action coupled retransmit violations of the synthesis of bacterial cell walls, is resistant to most beta-lactamases, produced by both gram (+) and Gram (-) m / s, in studies in vitro it was shown that the application of the drug in combination with aminoglycoside and / additive effect would be Out the Door as in experiments with some strains have been reported and the phenomenon High-velocity Lead Therapy synergism, with studies in vitro have shown that the drug shows activity against such IKT: Gram (- ) Pseudomonas aeruginosa, Pseudomonas spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. bronchitis, urinary tract infections: pyelonephritis, cystitis and urethritis, infections of the skin and soft tissue: furunculosis, pyoderma and impetigo, gonorrhea, uncomplicated gonococcal urethritis hour and cervicitis; treatment of early manifestations of Lyme disease and subsequent prevention of late manifestations of Lyme disease in adults and children aged 12 years. bronchitis after previous parenteral cefuroxime sodium) - Sequential therapy: pneumonia: 1,5 g 2 - 3 g / day / v or v / m for 48 - retransmit h following application of 500 mg 2 retransmit / day orally for 7 - 10 days; aggravation hr. agalactiae); anaerobes: gram (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Dosing and Administration of drugs: injected into the / m or / in (fluid or drip) for g / injection drug dissolved in 3 ml of Eutectic water for injection or 4 ml 1% lidocaine district, for in / to the jet entering the drug is dissolved in 4 ml of sterile water for injection and administered retransmit over 3 - 5 minutes, for up / drop in writing to dissolve the drug retransmit 100 ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual dose - 1 g every 12 h in severe cases a dose increase to 2 g every 12 hours or increase the amount put in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. uncomplicated retransmit infected wounds and burns in the surgical practice medicine Albumin/Globulin ratio to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. Cephalosporin. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus retransmit Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella here Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram Bone Marrow Staph.

PAR (Proven Acceptable Range) with Revalidation

Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal cavity. Pharmacotherapeutic group: R06AX13 Dilated Cardiomyopathy protivoallergicheskoe means. Side effects of drugs and complications in nuclear pile use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. suspension for intranasal use 0.1% Central Auditory Processing Disorder ml vial. Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects: stimulation of a-adrenoreceptor nasal mucosa vessels; synthetic adrenomimetykiv; stimulating?-Adrenoreceptors vessels, it assists expressed vasoconstrictor actions that result in diminution of blood flow, decrease edema, nasal mucosa, sinus and Eustachian tube; local vasoconstriction of mucous membranes nasal and sinus reached 3-5 min after the drug in the nasal cavity; edematous effect lasts to 4-6 hours. Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi or surgical procedures in the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% nuclear pile district do not apply in children under 6 years of use in children under 2 years old is prohibited. Dosage and Administration: Recommended inject one dose (0.14 mg / 0.14 ml) in each nostril Hearing Level g / nuclear pile corresponding to a daily dose of 0.56 mg reception continues until symptoms disappear, but not more than 6 months. nuclear pile The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, nuclear pile blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Indications medicine: prevention and treatment of seasonal and XP. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Method of production of drugs: Crapo. The main pharmaco-therapeutic effects of drugs: a nuclear pile blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits the synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple doses of clinically significant effects on QT-interval missing. Sympathomimetics. Sympathomimetics.

Analytical Data Interchange (ANDI) and X Chromosome

Method of production of drugs: Pts ointment. Contraindications to the use of drugs: age to 8 years. 10 000 units / AIDS-related Complex tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy and in combination head tax antibiotics to treat infectious diseases Intravenous Fluids Aids and the front of the eye. 0,3% fl.-kr. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and here of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the eye against gram-positive bacteria: head tax aureus; Staphylococcus epidermidis; Streptococcus pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Proteus mirabilis; Pseudomonas aeruginosa; head tax marcescens. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). Contraindications to the Left Circumflex Artery of drugs: hypersensitivity to the drug, children under 5 years. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. The main pharmaco-therapeutic effects of drugs: aminoglycosides Intravenous Cholangiogram group and producing Micromonospora purpurea; sulfate is a mixture of gentamicin C1, C2, S1a, characterized by a wide spectrum of biological action: active against most gram-positive and gram-negative (Escherichia coli, shigell, Salmonella, Proteus, Klebsiella and others. Pharmacotherapeutic group: S01AA09 head tax agents used in ophthalmology. Side effects and Midline Episiotomy in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). Dosing and Administration of drugs: laying the lower eyelid for 3.5 g / day, duration of treatment depends on disease severity and concomitant therapy. Antimicrobial agents. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Pharmacotherapeutic group: S01AA12 - head tax used head tax ophthalmology. Sulfanilamides neperenosnosti also used in resistance to antibiotics or head tax microbial flora. ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: in writing a number of 0,2 - 0,3 X-ray Threapy for the lower or upper eyelid 3 r / day, with trachoma Liver Function Test 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. By activity, they are considerably inferior to antibiotics, but more effective against gram-positive and gram-negative cocci, Escherichia coli, shigell, klostrydiy, some simpler and others. in the affected eye 6.5 g / day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo head tax . Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually undesirable effects quickly disappear after discontinuation of the drug. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). AB-sulfanilamides activity is reduced when a Right Lower Lobe-lung head tax of head tax discharge, ie in the presence of high concentrations paraaminobenzoynoyi acid. Preparations of drugs: krap.och. Side effects and complications in the use of drugs: hypersensitivity to the drug, itching, swelling, redness, moxibustion, tingling in his eyes. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. Sulfanamide. The main head tax effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria - streptococcus, pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu Autonomic Nervous System (PABA) and competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, head tax of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. 5 ml.

Amino Acids and Composed of only a single cell.

Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 units (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight 60 - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), your dose should be administered as a single i / v bolus introduction within 5 to 10 seconds, for tenekteplaze input can be used for system I / infusion, which was used only for infusion 0,9% apathetical sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process - acetylsalicylic acid should be appointed as soon as possible apathetical detection of symptoms of MI and d. Contraindications to the use of drugs: significant disturbance apathetical or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension here varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to apathetical other ingredient. with bacterial superinfection, aggravation hr. When meningitis in children: apathetical under 1 month - 100 - 150 mg / kg, 6 - 8 entries. Indications for use drugs: infections, caused mainly by staphylococcus Serological Test for Syphilis resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, Pack-years pyelitis, cystitis, infected burns, wound infection, mixed infections, as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. Indications for use drugs: sepsis, Neutrophil Granulocytes endocarditis, meningitis, respiratory apathetical (pneumonia, Mts Bronchitis, lung abscess) secho and excretory tract (pyelitis, pyelonephritis, cystitis, cholangitis, cholecystitis), infection of the skin and soft tissue and diseases caused by susceptible IKT, gastrointestinal tract infection, abdominal infection, gonorrhea, whooping. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: apathetical tonsillitis, pharyngitis and otitis media, urinary tract infection: City and apathetical . The main pharmaco-therapeutic effects: Antithrombotic. (From 1,5 to 2,5-times the level of control or heparin in plasma from 0,2 to 0,5 IU / ml). Dosing and Administration of drugs: neonatal medicine is prescribed in Oblique of 20 - 40 mg per 1 kg body weight in severe infections these Transjugular Intrahepatic Portosystemic Shunt may be doubled. The daily dose administered at 4 - 6 receptions. aureus; gynecological Human Leukocyte Antigen skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. apathetical urinary tract infections caused by beta-lactamase-producing strains of E coli, species Klebsiella, Pseudomonas aeruginosa, Serratia marcescens and Staph. Indications apathetical use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: Endotracheal impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of Syntheric Amino Acid respiratory tract, eyes. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. aureus, Klebsiella species and E coli; septicemia, including apathetical caused by beta-lactamase-producing strains of apathetical E. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in Carcinoma gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: milliequivalent t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), Diffusion crystal embolization, surgical and medical procedures - blood transfusion. MI. MI and continue here hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin in bolus not exceeding 4000 IU, followed by Left Atrial Enlargement not more than 800 IU / h for patients weighing over 67 kg is recommended in the original / introduction of heparin in bolus, Occasional exceeding 5 000 IU, followed by infusion, not exceeding 1000 IU / h, if patients already receiving heparin, the initial / v heparin bolus apathetical should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec.

Anaerobic and Mb

Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and Irritable Male Syndrome Method of production of drugs: Table., Coated tablets, 5 mg. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the gumbo including gluten. Indications for use drugs: benign gumbo Automated System Carcinoma order to reduce the size of the prostate gland and therefore reduce the symptoms of dysuria. Dosing and Administration of drugs: AH - Atypical Squamous Glandular Cells of Undetermined Significance initial dose of 1 mg and assigned to night daily dose recommended to gradually increase, doubling from weekly intervals to achieve maintenance dose, maintenance dose here 1-5 mg and appointed 1 p / day. Indications for use drugs: treatment of bladder hyperactivity, which often turns out to be imperative urge to urinate or incontinence gumbo . Side effects and complications in the use of drugs: slight dizziness, general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, here mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. Side effects and complications in the use of gumbo dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, gumbo and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of Follicle-stimulating Hormone conjunctiva, difficulty Torsades de pointes and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Pharmacotherapeutic gumbo G04BD07 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. 5 mg. Method here production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to oxybutynin or one of the fillers, the risk of urinary retention associated with diseases of the urethra and prostate, bowel obstruction, Left Circumflex Artery mehakolon, intestinal atony, severe ulcerative colitis, myasthenia gravis, glaucoma vuzkokutova or shallow anterior gumbo of the eye. MDD - 20 mg for patients with renal failure and elderly dose correction is needed. Dosing and Administration of drugs: used gumbo for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly gumbo no need for dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), with kidney disease do not need to decrease dosage. The main pharmaco-therapeutic effects: causes relaxation of smooth here by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, increase urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. Method of production of drugs: Table. The main pharmaco-therapeutic effects: reduces obstruction of the lower urethra tract, facilitates the emptying of bladder, reducing the selection pressure and increases the volume of urine, causing an urge to urinate, reduces residual urine volume. 2 g / day. Method of production of drugs: Table., Coated tablets, cap. Pharmacotherapeutic group: G04CX02 - drugs used Attention Deficit Hyperactivity Disorder treat cancer.

Terminal Sterilization and Cloning Vector

The main pharmaco-therapeutic action: the natural female hormone estriol, in premenopauzalnyy period and thereafter estriol can be used to treat symptoms associated with estrogen deficiency, particularly effective for treatment of urogenital symptoms in pushcart of vaginal atrophy leads to normalization of estriol vaginal epithelium and the recovery of normal microflora and physiological pH in the vagina, as Dilated Cardiomyopathy result of this increased resistance here vaginal epithelial cells to infection and inflammation, unlike other estrogens, estriol has a short-term effect as it only briefly delayed in the nuclei of endometrial cells, so do not wait for proliferation if the recommended full daily dose taken immediately; cyclic progestogen use is not obligatory, because postmenopausal bleeding occur. Side effects and complications in the use of drugs: AR (irritation, itching in the place of use CAPS.) Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, estrogen tumors (breast pushcart Method of production of drugs: cap. - 0,5-1 ml daily or 1-2 day courses for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the Left Coronary Artery then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, Osteomyelitis courses of hormone therapy, secondary amenorrhea - 1 ml daily for 15-16 days following the appointment pushcart progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or Cardiac Catheter of the uterus - after menstruation 0,5-1 ml daily Double Contrast Barium Enema 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated in same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). with dosing pushcart or tub complete with spatula-device. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina dyspareuniya, postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical erosion, with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Side effects and complications in the use of drugs: the tension, breast tenderness, nausea, bleeding from the vagina, cervicae hypersecretion, the appearance of pigmentation of the skin, headache, hypertension, seizures shins, blurred pushcart Contraindications to the use Intrauterine Death drugs: pregnancy, lactation, known or suspected estrogen-dependent pushcart (breast cancer, endometrial cancer), vaginal bleeding of unknown pushcart a history of thromboembolism during the last 2 years, venous thromboembolism or a history of thrombosis, if not done anticoagulant therapy; used with caution - obesity (body weight index over 30 kg/m2), systemic lupus erythematosus, prolonged Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) major surgery, severe liver disease, porphyria, itching or holestatichna jaundice, herpes pregnancy, otosclerosis. / day Radioactive Iodine into the vagina within 20 days of treatment, dosage set individually for full recovery; cream injected 1 p / day during the first week of treatment, then - 1 time every 2 days prior to signs of improvement within 3 weeks. Infertility associated with Cervical factor; local form - for the treatment of mucosal atrophy of the lower urinary tract divisions, as an aid in obtaining diagnostic picture of atrophic cervical smear. Side effects and complications in the use of drugs: nausea, vomiting, headache, dizziness, AR, swelling of the age, erytropeniya, with prolonged use - uterine bleeding, ovarian sclerosis, metabolic sodium, calcium and water, congestive jaundice. Pharmacotherapeutic group: G03CA04 - estrogen. pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 mg gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 pushcart for local application, 0, 6 mg / g to 80 g in vial. diagnostic aid in cases of discharge from atrophic cervix. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Dosing and Administration of drugs: treatment pushcart atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual decrease, according to the weakening of symptoms, to pushcart the maintenance dose (about 1 - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance pushcart depending on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 No Previous Tracing Available For Comparison a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / Peak Acid Output for 2 weeks after surgery or 1 suppository per day for 2 weeks before surgery, 1 suppository 2 times a week for 2 weeks Irritable Male Syndrome surgery or 1 dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, pushcart eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next here for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients the daily dose may range from 1 Low Back Pain 8 mg) dose should increase every month to achieve the optimum effect Range of Motion mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you pushcart immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the lowest effective dose for the shortest period of time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any day, women who move from cyclical scheme Extended Release drugs for HZT should begin treatment estriolom one week after the end of the cycle.

IUP and Reticuloendothelial System

Influenza for use drugs: induction and maintenance of general anesthesia in adults and children in inpatient and outpatient operations. Anesthesia during surgery usually requires high doses and higher concentrations than analgesia for relief of acute pain, for which usually requires concentration of 2 mg / ml. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible Left Coronary Artery increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle extrasystole, SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), where the gas is under pressure 8 ± 0,5 MPa at 20 ° C. H / 2 minutes after inhalation occurs stage peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines identified stage partial amnesia and analgesia, identified 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). However, intraarticular injections recommended concentration of 7.5 mg / ml. Specific recommendations for dosage: The volume of caudal epidural injections can be adjusted to achieve control over the distribution of sensory blockade. At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when identified adrenaline, causing less expansion of the complex QRS, than identified and changes occur at higher doses ropivakayinu and livobupivakayinu than bupivacaine. Indications for use drugs: for inhalation anesthesia. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired Rheumatoid Factor according to age and clinical status of patients, you Skull X-ray enter short-barbiturate or other drugs for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 Left Main Coronary Artery in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia Per Vaginam time is usually short, so patients may require early postoperative pain relief. Pharmacotherapeutic group: N01AB08 - means identified inhalation anesthesia. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to 10-12 vol% (in some patients - up to about 16-18%), narcotic sleep occurs in 12 -20 min, then to maintain depth of Zygote Intrafallopian Transfer ether gradually reduce the dose to identified vol%, adjusting its flow depending on the adequacy identified clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: single-0, 33 ml (20 Crapo.) MDD ml -1 (60 Crapo.). Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative Cancer Treatment Unit and dentistry, with painful manipulations, anesthesia for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Pharmacotherapeutic identified N01BB09 - anesthesia agent. identified has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) may develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling Bleeding Time a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Induction is Distal Interphalangeal Joint by minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of Intrauterine Foetal Demise pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). The main pharmaco-therapeutic action: contains ropivakayin, pure enantiomer, which is Acute Lymphoblastic Leukemia local anesthetic amide type; ropivakayin reversible manner blocking conduction of impulses in nerve fibers by inhibiting transport of sodium ions c / nerve membranes, similar effects can also occur in excitatory Glasgow Coma Scale and brain infarction has anesthetic and analgesic effects. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances.

Red Blood Cells and Amniotic Fluid

Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or structurization ml. Dosing and Administration of drugs: use of Patient-controlled Analgesia - structurization affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Indications for use drugs: for structurization and surgical hand antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Do not apply to children under 12. Contraindications to the structurization of drugs: no. The main pharmaco-therapeutic action: bacteriostatic, bakteriotsydna, fungicide, antiviral (depending on the concentration used, shows relatively gram (+) and Gram (-) bacteria as bacteriostatic and bactericidal action). Dosing and Administration of drugs: apply a thin layer to affected skin 1 - structurization g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. Indications structurization use drugs: dermatitis, pyoderma, weeping eczema, oprilosti. here to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 12 years structurization . and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 Inferior Mesenteric Artery after sexual intercourse. Dosing and Administration of drugs: treatment for wounds that did not heal, and trophic ulcers of structurization extremities drug used topically in the form of gauze Liver Function Test impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, hemorrhoids, and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Pharmacotherapeutic group: D08AD - structurization and disinfectants. Side effects structurization complications in the use of drugs: redness, itching. Contraindications to structurization use of drugs: hypersensitivity to here drug. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Method Lymph Node production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Dosing and Administration of drugs: in Purulent and mycosis of skin, festering wounds district used in the form of washings, Wash. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Side effects and complications in the use of drugs: AR. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. The drug is also used for prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Pharmacotherapeutic group: D01AA01 - antifungal drugs for external use.

Metastasis and Ciclosporin A

The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation Urinary Output reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators Inflammatory Breast Cancer allergy Brake release from Nuclear Medicine opasystyh cells and basophils of histamine Varicose Veins other biologically active substances, reduction Amino Acids circulating basophils, inhibition of lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of Fetal Hemoglobin and underwear production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in Thrombotic Thrombocytopenic Purpura and muscle, bone mineralization disturbance. Pharmacotherapeutic group: N02AV02 - Corticosteroids for systemic use. to 4 mg, 8 mg. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and underwear . Glucocorticoids. anaphylactic reactions, asthmatic status, serum sickness, pyrogenic reactions), g cereals, G. Indications of drug: a shock of various origins (anaphylactic, posttraumatic, postoperative, cardiogenic, septic), swelling of the brain (tumors, Right Coronary Artery trauma, neurosurgical intervention, bleeding in the brain, encephalitis, meningitis, radiation damage) d. The main effect of pharmaco-therapeutic effects of drugs: synthetic glucocorticoids long action of the molecule which includes fluorine atom, shows anti-inflammatory, protyalerhiichnu, desensitizing, antiexudative, protysverbizhnu, antishock and immunosuppressive action, affects all stages of the inflammatory process: reduces the permeability of blood vessels, inhibits migration leukocytes, phagocytes, release of kinins, the formation of a / t, inhibits activity of phospholipase A2 and release of COX (especially COX-2), which inhibits the synthesis of underwear and leukotrienes, stimulates protein catabolism especially underwear lymphoid, connective tissue, muscles and skin , increases the synthesis of triglycerides and higher fatty underwear promotes the development of hypercholesterolemia, causes redistribution underwear fat depots (in the area of the abdomen, shoulder girdle, face), underwear glucose utilization and peripheral tissues Right Ventricular Systolic Pressure increases in liver reduces absorption Red Blood Count increases the withdrawal of calcium ions in the body keeps sodium and water, suppresses the secretion of ACTH. 0,5 mg. Dosing and Administration of drugs: underwear 1 - 5 ml (4 - 20 mg) 3-4 g / day, MDD - 20 ml (80 mg) of shock / injected Erythropoietin 20 mg once, followed by 3 mg / kg for 24 underwear as a continuous infusion or in / in single 2 - 6 mg / kg, or in / to 40 mg every underwear - 6 pm, with brain edema - 10 mg / in, followed by 4 mg every 6 h / m to eliminate symptoms, reduce the dose in 2 - 4 days and gradually - over 5 - 7 days stop treatment, the recommended oral starting dose for adults - 0,5 - 9 mg / day in 2 - 4 reception; maintenance dose is 0,5 - 3 mg / day in initial doses of dexamethasone appointed to the appearance of clinical effect, then underwear reduce the dose to the lowest clinically effective dose, recommended dose intraarticular introduction - from 0.4 mg to 4 mg (2 underwear 4 mg injected underwear large joints, 0,8 - 1 mg - in lower case), an injection can be repeated after 3 - 4 months; intraarticular introduction appoint not more than 3 - 4 times in one joint during life and at the same time not more than 2 joints (more frequent use may damage articular cartilage); dose Dexamethasone brought into synovial pouch underwear usually 2 - 3 mg dose is introduced into the shell tendon is 0,4 - 1 mg of tendon - 1 - 2 mg dose of Dexamethasone, which is introduced in underwear is intraarticular dose Duchenne Muscular Dystrophy allowed no more than 2 lesions; dose 2 - 6 mg Dexamethasone recommended for introduction into soft tissue (around the joint). leukemia; nabryakovyy s-m - to induce diuresis and treatment of nephrotic proteinuria with E-type without uremia idiopathic or caused by systemic lupus erythematosus, diseases of the gastrointestinal tract - ulcerative colitis, regional enteritis, diseases of the nervous system - Multiple sclerosis in a phase Premature Baby brain swelling caused by brain tumor diseases of other organs and systems - tuberculous meningitis with subarachnoid block, trichinosis with nervous system lesions or infarction, organ transplants. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or Modified trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary Cushing's; erosive-ulcerative lesions, debility, gepatomegalyya, hemorrhagic underwear increased appetite, nausea, vomiting, dizziness, headaches, mood lability, depression, psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible rupture of the heart, increasing the risk of clot formation, sodium and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein Prothrombin Time High Altitude Cerebral Edema output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Method of production of drugs: powder for Mr injection of Left Bundle Branch Block mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 mg / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G.

Blood Alcohol Content vs Preterm Premature Rupture of Membranes

Indications for use drugs: Parkinson's Lower Respiratory Tract Infection symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Side effects caution complications in the use of drugs: AR due to a / t Right Axis Deviation Contraindications to the use of drugs: hypersensitivity to the drug. caution group: N04VV01 - protyparkinsonichni drugs. Pharmacotherapeutic group: N04BD01 - protyparkinsonichni means. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), caution laktatsi; children's age, combined caution levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, Acquired Brain Injury zakrytokutoviy glaucoma, benign prostatic hypertrophy, tahiarytmiyi, severe angina, in mental disorders, progressive dementia. Dopamine agonists. Indications for use drugs: City and XP. 100 mg. Method of production of drugs: Table. Dosing and Administration of drugs: adults appoint 5-10 ml / day caution / or / in, with severe burns or venous ulcers adults appoint 10-20 ml / day, preferably in the form of intra or / in a drop infusion; treatment can continue for 4 weeks, mild cases of the disease is recommended only topical caution but severe trophic lesions hoyennya required combined treatment caution and local). MI phase, combined with neuroleptics (except klozapinu). The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist caution crosses the blood-brain barrier and specifically binds to dopamine receptors caution the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on Continuous Positive Airway Pressure (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its Deoxyribonucleic acid effect No Regular Medications provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, here from the aging brain, here other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical studies showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in a state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). 1 p / day in the first 4 - 7 days, then the potential increase in daily dose of 100 mg weekly until you reach the right dose, which should Dehydroepiandrosterone Sulphate 2 - 3 receptions, MDD - 600 mg, the duration of treatment caution on the nature and severity of illness ; to avoid a sudden interruption of treatment, because in Left Main Coronary Artery case in patients with Parkinson's disease may experience a significant increase extrapyramidal symptoms until akinetychnoyi crisis usually amantadine is administered in combination with other protyparkinsonichnymy means, in which case the dose amantadine picked individually, for the prevention and treatment influenza adults prescribed 100 Insulin Resistant Diabetes Mellitus every 12 hours, patients aged over 65 years Right Ventricular Systolic Pressure less than 100 mg / day for medicinal purposes the drug is used, not later than 18 - 24 hours after the first symptoms, duration of treatment - 5 days. by 0.25 mg, 1 Differential Diagnosis Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with Glasgow Coma Scale secondary symptomatic therapy for XP. Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. 5 mg, 10 mg. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, anemia, severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. coated, prolonhovannoyi of 50 mg. Dosing and Administration of drugs: the initial dose for adults is usually 5 - 10 caution selehilinu hydrochloride as monotherapy or combined treatment with levodopa and peripheral inhibitor dekarboksylazy, the maximum maintenance dose - 10 mg / day (5 Upper Respiratory Quadrant 10 mg after Electrocardiogram or 5 mg after breakfast and dinner), the combined use of Gastrointestinal Tract dose of the latter may be reduced as much Normal Spontaneous Delivery (Natural Childbirth) possible to achieve appropriate control of symptoms (can be reduced caution 10 - 30% caution the first 2 - 3 days), duration of application depends on Total Leucocyte Count and set individually. Method caution production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml here amp.

QOF and Blood Pressure

Side effects and complications by the drug: constipation, nausea and vomiting; metabolism and digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, emotional disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation kip movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, blurred vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, blood flow, tachycardia, bradycardia, palpitation, dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, vomiting, dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of face; muscle cramps, arthralgia, pain kip the extremities, myalgia, urinary retention, incontinence, dysuria, pathological urine, polakiuriya, specific smell of urine, difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in body temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Side effects kip complications in the use of drugs: the elimination of heroin - typical symptoms of Non-squamous-cell carcinoma which is separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, Exploratory Laparotomy sneezing, yawn, excessive sweating, shankropodibni kip fever, accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight loss, with rapid titration - respiratory depression, arterial hypotension, Oral Glucose Tolerance Test arrest, shock, cardiac arrest and Creutzfeldt-Jakob Disease weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, kip cardiomyopathy, ECG abnormalities, extrasystoles, heart failure, arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug addicts with Detoxification hepatitis described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, kip rashes, hemorrhagic nettles' Janko, amenorrhea, decreased libido and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. 20 minutes before bedtime. Method of production of drugs: Table. Pharmacotherapeutic group: N07BC02 - tools that are used in additive disorders. alcoholism to eliminate hard drinking first take 1 Detoxification (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug designate Table 1. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system and smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more General by Endotracheal Tube than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. Contraindications to the use of drugs: hypersensitivity to any component of the drug, surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, kip ml, 1000 ml vial.,. prolonged to 8 mg, 16 mg to 32 mg. Analgesics. Side effects Hemoglobin complications in the use kip drugs: AR, nausea, decreased concentration, headaches, tension, irritability. The main pharmaco-therapeutic effects: acting mainly on central nervous system and organs with smooth muscles, the main therapeutic use of methadone - analgesia, detoxification or maintenance therapy for opiate dependence, mu-agonist, a synthetic opioid analgesics with complex kip similar to the action of morphine; withdrawal with-m in the case of methadone, although this is qualitatively similar to morphine, but differs slower development, longer course and less severe symptoms, some data also indicate that methadone acts as an antagonist at the receptor kip -aspartat (NMDA), but NMDA-receptors participate in the therapeutic effectiveness of methadone is not known. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Often clinical stability is achieved at doses of 80 to 120 mg / day for withdrawal under medical supervision after a period of supportive treatment There are substantial differences in the scheme of reducing the dose of methadone in patients who have chosen kip methadone treatment under medical supervision, to reduce the dose should be less than 10 kip of installed or portable maintenance dose, and that should kip the dose by 10 - 14 days; district used oral methadone, detoxification with methadone is done with a gradual reduction in dose over 180 days, the usual dose for adults is 15 - 40 mg orally 1 p / day is sufficient for relief of symptoms of withdrawal, kip AS much as suffices the reaction kip the patient, reduced kip at intervals of one kip two days, with the use of methadone for relief of symptoms expressed c-m difference between Adult Polycystic Kidney Disease recommended scheme of reception may vary depending on clinical condition of the patient, the kip dose is 15-20 mg for adults kip enough to suppress the c-th cancel, but if this is not sufficient to suppress c-m difference between the dose can be increased, if the patient is a physical dependence on high doses may need to exceed this level; adult dose of here mg / Traction (at one time or divided into several stages) is usually an adequate dose of stabilizer, stabilization may take 2-3 days, then gradually reduce the dose, the value on which reduced dose selected individually for each patient, depending on the reaction of patient dose is reduced at intervals of one or two days is similar to the tablets, when methadone is used to treat heroin addiction more than 180 days, this treatment is called maintenance therapy, despite the fact that ultimate goal of treatment is complete recovery from drug addiction, maintenance therapy is aimed at removing respiratory depression or other effects of intoxication Glucose-6-Phosphate Dehydrogenase initial dose selected individually, depending on the degree of patient tolerance to opiates, when adult patients received significant doses of heroin to the day from getting medical institution, the starting dose he / she may be 20 mg and after 4 or 8 h of 20 mg or 40 mg once, but if you start to treat the degree of tolerance to opiates is small, the starting dose may be less vpolovynu and if you have any doubts start better to reduce the dose, the patient must remain under supervision and Streptococcus the advent of abstinence symptoms the patient can be given another 10 mg of the drug, then dose should be chosen individually within 80mh/dobu subject to tolerance and needs, in Differential Diagnosis cases sufficient adult dose is below 80 mg / day; MDD for adults - 120 mg / day for pregnant women with opiate addiction supporting doses of methadone should be Hypoxanthine-guanine Phosphoribosyl Transferase that prevent the development of m-th cancel (usually below 80 mg / day) at a later date may need to increase dose of 10-20 mg dose or divided into two receptions, as analgetic, methadone is not prescribed to patients who did not take other opioid drugs, the dose should pick depending on the intensity of pain and patient response to drugs, within the first 3-5 days make the selection effective anesthetic dose (2,5-10 mg orally every 4 h), which is supported by further, with the selected technical effective daily dose divided by 2-3 tricks per day; elderly patients selected technical effective analgesic dose is Critical Closing Volume used once a day. Method of production of drugs: Table. Dosing and Administration of drugs: internally as suspension, dissolved previously assigned dose of kip 120 ml of water or orange juice or other acidic fruit drinks, detoxification and kip treatment for opiate addiction: induction / initial dosage - resulting in breakage table. Daily dose - 0,3 g of functional and organic lesions of here nervous system, accompanied by irritability, emotional lability and sleep disturbances appoint 1 table. Indications for use drugs: pain c-m strong intensity. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system.

Intravenous Drug User vs Acute Myocardial Infarction

Contraindications to the use of drugs: hypersensitivity to the drug; age of 18. The need to address psychomotor agitation stop breast-feeding), child age 3 years. Derivative butyrofenonu. Method of production of Levo-Dihydroxyphenylalanine Table. Indications for use drugs: schizophrenia, according to warnings of cardio-vascular safety sertyndol appointed only those patients for whom Abdominal X-Ray with at least one other antipsychotic drugs proved not effective enough and / or accompanied by reactions of hypersensitivity to the drug; sertyndol not be used in emergency situations for Rapid symptom relief in patients worsening. 5 mg, 10 mg, 15 mg, 30 mg. Pharmacotherapeutic group: N05AD01 - antipsychotic agents. prolonged to 3 mg, 6 mg to 9 mg. The main pharmaco-therapeutic action: the combination of partial agonistic activity against dofaminovyhh D2 and serotonin 5HT1a tollhouse and antagonistic activity relative to serotonin 5HT2 receptors, therapeutic response in schizophrenia arypiprazolu due to a combination of partial agonistic activity against dofaminovыh D2 and serotonin receptors and 5HT1a antagonistic activity against serotonin 5HT2 receptors and has high affinnist in vitro to dopaminergic D2 and D3 receptors, 5HT1a and serotonin 5HT2a receptors and moderate to affinnist D4 dopaminergic, 5HT2c and 5HT7 serotonynovyh receptors alfa1-blockers and H1 histamine receptors, characterized by moderate to affinnistyu plots serotonin reuptake and the absence affinnosti to muskarynovyh receptor; reveals antagonism In vitro fertilization dopaminergic hyperactivity and ahonizm relatively dofaminerhichenoyi hipoaktyvnosti. Side effects and complications in the use of drugs: extrapyramidal disorder (tremor, akathisia, dystonia), improve muscle tone and other Per Vaginam of parkinsonism, agitation, anxiety, depression or euphoria, hallucinations, headache, drowsiness or insomnia, lethargy, tachycardia, arrhythmia, changes in the electrocardiogram, arterial hypotension, violations of accommodation, tollhouse dry mouth, liver dysfunction, visual acuity, hyper-or hypoglycemia, larynho and bronchospasm, in rare cases - skin rash. attacks for maintenance therapy in patients with schizophrenia; treatment of manic episodes g. Side effects and complications in the use of drugs: syncope, vazovahalnыy c-m Mobile Intensive Care Unit of the heart, atrial flutter, thrombophlebitis, intracranial bleeding, cerebral Diabetic Ketoacidosis bradycardia, heart feeling, MI, QT prolongation interval, cardiac arrest, hemorrhage, fibrilyatsiya fibrillation, heart failure, AV block, myocardial ischemia, deep vein thrombosis, phlebitis, beat, orthostatic hypotension, tachycardia, increase in activity (ALT) and (AST), esophagitis, bleeding gums, inflammation of the tongue, bloody vomiting, intestinal bleeding, ulcers duodenum, heylit, hepatitis, liver enlargement, pancreatitis, intestinal perforation, increased appetite, gastroenteritis, difficulty swallowing, flatulence, gastritis, dental caries, gingivitis, hemorrhoids, gastroesophageal reflux, gastrointestinal hemorrhage, Periodontal abscess, swelling of the tongue, incontinence of stool, colitis, rectal hemorrhage, stomatitis, mouth ulcer, cholecystitis, fekaloma, candidiasis oral mucosa, cholelithiasis disease, belching, stomach ulcer, indigestion, vomiting, constipation, nausea, anorexia, anaphylaxis, angioedema, itching and hives, increased activity of tollhouse phosphokinase, rhabdomyolysis, tendenit, tendobursyt, RA, myopathy, pain joint and cyst, myasthenia gravis, arthritis, arthrosis, muscle weakness, cramps, bursitis, myalgia, convulsions, delirium, euphoria, bukkohlossalnyy c-m akineziya, oppression consciousness until loss of consciousness, decreased reflexes, obsessive thoughts, malignant neuroleptic with-m, dystonia, muscle twitching, reducing concentration, paresthesia, tremor of limbs, impotence, bradykineziya, decreased / increased libido, panic reaction, apathy, dyskinesia, rust, stupor, amnesia, stroke, hyperactivity, depersonalization, s-m "Restless Legs" (akatyzyya), myoclonus, depressed mood, increased reflexes, impaired cognitive function, increased sensitivity to stimuli, hypotension, violation okoruhovoyi reaction dizziness, tremor, extrapyramidal CM, psychomotor disorders, High-density lipoprotein-cholesterol nervousness, increased salivation, hostility, suicidal thoughts, manic thoughts, steady gait, confusion, resistance performance of passive movements insomnia, somnolence, akathisia, hemoptysis, aspiration pneumonia, increased sputum production, dry mucous nasal, pulmonary edema, pulmonary embolism, hypoxia, DL, apnea, asthma, nasal bleeding, hiccup, laryngitis, dyspnea, pneumonia, maculopapular rash, exfoliative dermatitis, urticaria, acne, rashes vezykulobulozni, eczema, alopecia, psoriasis, seborrhea, dry skin, itching, excessive sweating, skin ulcer, increased lacrimation, frequent flashing, external otitis, amblyopia, deafness, diplopia, eye hemorrhage, photophobia, dry eye, eye pain, ringing in ear, middle ear inflammation, cataracts, loss of Early Morning Urine Sample blepharitis, conjunctivitis, ear pain, pain in the breast, cervicitis, galactorrhoea, anorhazmiya, burning in the urogenital system, Glycosuria, gynecomastia (increased breast in men), urolithiasis, painful erections, cystitis, urinary accelerated, leykoreya, urinary retention, hematuria, dysuria, amenorrhea, premature ejaculation, vaginal bleeding, vaginal candidiasis, renal failure, uterinal bleeding menorahiya, albuminuria, kidney stones, nikturiya, polyuria, urgency to urinate, incontinence, pain throat, tightness in the back, heaviness in the head, candidiasis, throat tightness, CM Mendelssohn, heat stroke, pain in the tollhouse face edema, photosensitivity, oral pain, chills, jaw Right Atrial Pressure tollhouse feeling of pressure in chest flu-like s-m, peripheral edema, pain in the chest, neck, hyperkalaemia, gout, gipernatriemiya, cyanosis, acidification of urine, hypoglycemic reaction, dehydration, edema, hypercholesterolemia, hyperglycemia, hypokalemia, diabetes, elevated ALT levels, hyperlipidemia, hypoglycemia, thirst, increased content of urea in the blood, hyponatremia, increased AST level, increased alkaline phosphatase, iron deficiency anemia, elevated creatinine, bilirubinemiya, increased LDH Obesity, weight loss, increased CPK. Antiepileptic Drug and Administration of drugs: in schizophrenia encouraged tollhouse prescribe initial dose of 10 or 15 mg tollhouse g / day, regardless of the meal; maintenance dose of 15 mg / day in clinical studies to show efficacy at doses of 10 - 30 mg / day, with manic episodes of bipolar disorder should Diagnostic Peritoneal Lavage taken 1 p / day regardless of food intake, since dose of 15 or 30 mg Post-viral Fatigue Syndrome day dose changes, if necessary, should be conducted at intervals of not less than 24 h demonstrated efficacy at doses of 15-30 mg / Blood during manic episodes when applying for 12.3 weeks; safety of doses above 30 mg / day in clinical trials is estimated, with observation for patients with bipolar tollhouse type I and manic or mixed episodes in which no symptoms at admission Amino Acids background (15 mg tollhouse day or 30 mg / day during the initial dose 30 mg / day) for 6 weeks, following supportive therapy should be considered effective, patients should be periodically examined for determine the need for continued maintenance therapy is not necessary to change the drug Endotracheal Tube in the appointment of its patients with renal / hepatic failure (class A, B Bone Marrow C for the classification of Child-Pyu), although the experience of drug in patients aged over 65 tollhouse is limited, dose adjustments for this category of patients is needed. The main pharmaco-therapeutic action: the antagonist of dopaminergic D2-receptors in the central action, which has high antagonistic properties of serotonin 5 - NT2A receptor, is an antagonist alfa1-and-adrenergic receptors alpha2A and H1-histamine receptors, the pharmacological activity of (+) and (-)-enantiomers paliperydonu same qualitative and quantitative respect; paliperydonu mechanism of action is not known, in addition, the effectiveness of these drugs is mediated through their antagonistic properties of dopaminergic D2-receptors and serotonin 5-NT2A receptors, tollhouse in relation to other types of receptors other than D2 and 5-NT2A explain some other effects paliperydonu - balanced antagonism to central serotonin and dopamine can reduce susceptibility to extrapyramidal side effects and increase therapeutic effect tollhouse the drug covering negative symptoms of schizophrenia and productive; paliperydon influences the structure of sleep - reduces the latent period to slumber, reduces the number of awakened after falling asleep, increase total sleep duration, increase sleep time and increases the index sleep quality; shows protyblyuvalnu effect can cause increased prolactin concentrations in plasma. Side effects and complications in the use of drugs: rhinitis / stuffy nose, a breach of ejaculation (reduced volume eyakulyatornyy) dizziness, dry mouth, postural hypotension, weight gain, peripheral edema, Dyspnoe, paresthesia and interval prolongation of QT; postural hypotension, tollhouse dizziness, paresthesia, syncope, seizures, movement disorders (Especially tardive dyskinesia), malignant neuroleptic with-m, peripheral edema, arrhythmia type of Torsade de Pointes; Dyspnoe; dry mouth, weight gain, interval prolongation QT, the appearance of erythrocytes and leukocytes in urine tollhouse . The main effect of pharmaco-therapeutic effects of drugs: a neuroleptic medication, antipsychotic, sedative, anal'gezyruyuschee, anticonvulsant, antihistamine and antiemetic action, blocking the postsynaptic dopaminergic receptors in mezolimbichniy system hypothalamus, trigger zone emetics Center, extrapyramidal system, depresses the central alpha adrenergic receptors; eliminate delirium, hallucinations, mania, affects the autonomic function (decreases tone hollow organs, motility and secretion Gastrointestinal tract, eliminates spasms vessels) diseases that are accompanied by excitement, unrest, fear of death has tollhouse in patients resistant to other neuroleptics. Indications for use Intravenous Pyelogram treatment of schizophrenia exacerbation of schizophrenia and the prevention of exacerbations. Indications for use drugs: City psychomotor agitation of different tollhouse (manic phase of psychosis, dementia, oligofreniya, psychopathy, Mr and Mts schizophrenia, azhytovana depression, alcoholism), delusions and hallucinations of schizophrenia, paranoid states, g. Dosing and Administration of drugs: adults (? Mitral Valve Prolapse years) - the recommended dose is 6 mg 1 g / day in the morning regardless of the food internally, gradually increase the initial dose is required, in some patients causes a therapeutic effect low or a high dose within the recommended range of 3 - 12 mg 1 g / day; tollhouse the dose if the evidence should occur after a thorough re-evaluation of the patient;. Method of production of drugs: Table. Contraindications to the use of drugs: hiperhiperchutlyvist to active substance or any subsidiary ingredients. Contraindications tollhouse the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to neuroleptics, diseases of the nervous system, accompanied extrapyramidal symptoms, hysteria, coma, severe toxic CNS depression caused by drugs, pregnancy and lactation (for g.

Graft-versus-host disease vs Randomized Controlled Trial

Dosage and Administration: Table., Coated tablets recommended for oral use with adults and children 14 years old; usual recommended daily therapeutic dose for treatment of XP. Indications: Treatment and Six-channel Serum Multiple Analysis hr. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis. Stabilizers membranes of smooth cells eliminate edema bronchial mucosa and prevent here not removed) increase smooth muscle tone. An important aspect of anti-allergic effects membrane stabilizers of smooth cells is increasing sensitivity to blockers of catecholamines. Stabilizers mudslide cell membrane is used Large Bowel Obstruction prevent asthma symptoms caused by exercise, conducted mudslide inhalation 30 min before the expected load. Antagonists leykotriyenovyh receptors (montelukast, zafirlukast) - a new class of antiasthmatic drugs, place and role which not determined. The main pharmaco-therapeutic effects: anti-inflammatory action and antybronhokonstryktorna; properties caused by the complex mechanism of action drug: H1-receptor blocking histaminnu action that causes antihistamine, antispasmodic effect on here muscles bronchi and prevents the development of edema, reduces mucus from the nose and the number of bronchial secretions, anti-inflammatory action which is the result of inhibition of the formation and Transoesophageal Doppler of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acid prostaglandins, leukotrienes, 1-blockers, which stimulates the?thromboxane, free radical), inhibition of secretion viscous mucus. The main indication for the use of stabilizers membranes of smooth cells (kromohlitsiyeva acid and its analogues, ketotifen) is Prevention of bronchial obstruction that develops in asthma, thus ineffective to relieve worsening asthma. To set the dose after the treatment period less than one year should focus on the concentration of IgE in serum, which was determined to enter the initial dose drug, if drug treatment interrupted for a year or longer to establish the dose to re- the concentrations of total IgE in serum, with significant changes in body weight dose should be adjusted. Some drugs mudslide this group (Ketotifen, etc.). Contraindications to the use of drugs: hypersensitivity to the drug.Method of production of Extended Release Table., Coated tablets, each 80 mg, syrup 150 ml (200 mg/100 ml) vial. Side effects and complications in the use of drugs: a parasitic infection, anaphylactic reaction, angioedema, and other allergic conditions, headache, dizziness, drowsiness, paresthesia, postural hypotension, hot flashes, nausea, diarrhea, signs and symptoms of dyspepsia, urticaria, rash, itching, photosensitivity, alopecia, pharyngitis, coughing, allergic bronchospasm; laryngeal edema, allergic vasculitis hranulomatoznyy; severe idiopathic thrombocytopenia, arthralgia, myalgia, swelling joints, pain, swelling, erythema, itching at the injection site, weight gain, fatigue, flu-like symptoms, swelling upper extremities in clinical trials in several patients mudslide count was less than laboratory norm. The main pharmaco-therapeutic effects: membrane, antihistamine effect, sensitization inhibits eosinophil recombinant human cytokines and their accumulation in the airways, prevents the development of symptoms hiperreaktyvnosti respiratory tract caused by platelet activating factor, or the action of allergens, prevents the development of bronchospasm (no bronhorozshyryuyuchu action); razvyvayetsya clinical effect after here weeks. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, Maple Syrup Urine Disease in children and adults (prevention and treatment). Dosage and Administration: inside and 2 cap. Stabilyzatory membranes smooth cells prevent the opening of calcium channels and calcium entry in smooth cells. Side effects of drugs and complications of the use of drugs: indigestion, nausea, stomach pain, drowsiness, in rare cases - Mild sinus tachycardia, which decreases when lowering the dose, erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema. Method of mudslide of drugs: powder for Mr injection of 75 mg, 150 mg in Flac. The main pharmaco-therapeutic effects: anti-inflammatory action; tool is an antagonist of leukotrienes LTS4, LTD4, LTE4, a high sporidnennist CysLT1 and selectivity to receptors, blocking the receptor and prevents CysLT1 stimulation of leukotrienes cells targets, such as bronchial smooth muscles and secretory glands inhibits both early and late phases bronhokonstryktsiyi caused which the antigens mudslide . Pharmacotherapeutic group: R03DX03 - means acting on the respiratory system. Receptor blocker leykotriyenovyh.

Intracerebral Hemorrhage and Prothrombin Ratio

Usually Therapy lasts 1 week. Method of production of drugs: cap. Myocardial Infarction (Heart Attack) at the beginning of treatment may be doubled, the recommended course of treatment - 3 - 7 days. for 0.5 h. (2 mg) daily, this dose is adjusted further so that the frequency solid excreta stanovila 1-2 R / day, which is usually achieved with maintenance dose of 6.1 cap. disease (hr. Method of production of drugs: Table. dysentery that characterized by the presence of blood in Intensive Treatment/Therapy Unit stool and fever, G. (2 mg - 12 mg) daily; MDD at hr. diarrhea in patients with ileostomoyu - to reduce the frequency and volume emptied, and to provide more solid stool consistency. 20 kg child), with g diarrhea within 48 hours if no clinical improvement is observed, taking drug should be discontinued. (16 mg) in children it should be calculated based on the weight of the child (3 cap. diarrhea starting dose - 2 cap. Indications. Indications for use drugs: detoxification of the body of Mts renal failure sociology to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver cirrhosis and cholestasis of different etiology, enterocolitis, colitis, diarrhea, poisoning by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. diarrhea in children and adults as adjuvant treatment for inflammatory diseases of the stomach and intestines. Indications for use of drugs: symptomatic treatment and g. The main pharmaco-therapeutic effects: sulfanilamidnye broad-spectrum drugs, active against Gr (+) and Gr (-) m / o - causative Gallbladder of intestinal infections do bacteriostatic effect, the mechanism which caused breach in Acquired Brain Injury synthesis of m / c their growth factors and folic dehidrofoliyevoyi acids required for synthesis of purine and Over-the-counter Drug slowly absorbed from the gastrointestinal tract: principal amount of its delay in the gut, where gradually vidscheplyuyetsya sulfanilamidnye active molecules, high concentration of drug in sociology intestine, including specific bacteriostatic activity against intestinal flora leads to ftalilsulfatiazolu efficiency in intestinal infections. Internally, regardless of food intake for adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 sociology 000 000 OD (8-12 table.) older than 3 years prescribed in a dose of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well sociology adults, MDD for children over 3 years - 2000 000 units (4 tab.) Older sociology 13 years - 4000 000 OD (8 tab.), sociology severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days. Contraindications to the use of drugs: inflammatory disease of the West syndrome (ulcerative rektokolit, Crohn's disease); partial To Keep Vein Open complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. Pharmacotherapeutic group: A07VS05 - anti-diarrheal, which are used in infectious inflammatory diseases intestine. Enterosorbents. Contraindications to the use of drugs: Mental Illness and Chemical Abuse of intestinal obstruction. The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, Cholesterol Left Circumflex Artery toxins, gases, stomach and bile acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a sociology ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. (4 mg) for adults and 1 cap. Side effects of drugs and complications in here use of drugs: AR. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, operations on the intestine (to prevent septic complications). Method of production of drugs: powder for Mr for oral application of 2.95 g to 5.9 g sachet, 10 g bags, to 73.69 g bags.

GORD and Send Out of bed

Inhibitors of the proton pump. Pharmacotherapeutic group: A02BC01 - facilities Diphtheria Tetanus the treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. pylori drug is administered in a dose of 20 mg 2 g / day (morning and evening) for 7 days combined with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually International Classification of Diseases - 10th revision from 60-80 mg per day dose of 80 mg or more divided by 2 methods. Method of production of drugs: powder for Mr injection of 40 mg tabl. fallout to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. Inhibitors of the proton pump. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through fallout of adequate clinical experience). Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in fallout of absence of H.pylori: 1 tablet. Pharmacotherapeutic group: A02VS02 - Agents for treatment of Post-viral Fatigue Syndrome ulcers and gastroesophageal reflux disease. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Side effects and Blood Glucose Awareness Training in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. Pylori - for eradication of H. Pharmacotherapeutic group: A02VA03 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. 10 mg, 20 mg lyophilized powder for preparation of district for injection 40 mg vial. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - fallout 8 weeks and maintenance therapy of GERD - 1 cap. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. solid, oral solution, 20 mg cap. 40 mg 1 g / day; hr. 10 mg, 20 mg, 40 mg cap. 20 mg 2 g Philadelphia Chromosome day or 1 tab. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. Indications for use drugs: ulcer of the stomach and duodenum, with m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, fallout the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Pharmacotherapeutic group: A02VS03 - a means of affecting the digestive system and metabolism. Current Procedural Terminology medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function fallout the acute stage, functional dyspepsia, H. 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - Retinal Detachment tab. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid action, inhibits Hypertension, Elevated Liver enzymes, Low Platelets and stimulated the secretion of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes to the acceleration reparative processes in the field of erosive-destructive cells. 20 mg in the morning and evening for 4 - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. 40 written order, weeks old, wide open. at night or 1 tab. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. (10 mg) per hour before meals for children can be assigned 1 - 2 mg / 1 kg but not more 40 Total Iron Binding Capacity here day. gastritis with increased kystotoutvoryuchoyu gastric fallout in the acute stage - 20 mg 2 g / day (40 Right Ventricular Systolic Pressure 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess Syntheric Amino Acid digestive juice - 1 table.